News

Mark Rubin, M.D., will lead an investigation into the genomics of prostate cancer progression. Read more

Treating terminally ill cancer patients with chemotherapy in the months or weeks before their deaths was not found to improve patients' quality of life and may actually do more harm than good, according to a new study led by Holly Prigerson, Ph.D. Read more

Lung cancers attract circulating immune cells to the tumor mass, where the cancer reprograms them to support its growth and progression, according to a study by Vivek Mittal and colleagues. Read more

The promise - and challenges - of copper depletion therapy for triple negative breast cancer. Read more

Harold Varmus, M.D., discusses his career and the future of cancer care in interviews with JAMA and Scientific American. Read more

Double-drug therapy may be just as effective as triple-drug therapy, with less toxicity, for some patients with transplant-ineligible multiple myeloma, according to a study by Ruben Niesvizky, M.D. Read more

Mark Souweidane, M.D., is on the front lines of research into DIPG, a rare brain tumor that kills 250 children every year in North America. Read more

Dean Laurie Glimcher, M.D., made the list of Crain's New York Business Most Powerful Women 2015. Read more

Study into the mechanisms of tissue stiffening prompts discoveries about cellular splicing of key proteins. Read more